Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

被引:0
|
作者
Duman, BS
Türkoglu, C
Akpinar, B
Güden, M
Vertii, A
Dak, E
Çagatay, P
Günay, D
Büyükdevrim, AS
机构
[1] Kadir Has Univ, Sch Med, Dept Med Biol & Genet, TR-80810 Istanbul, Turkey
[2] Kadir Has Univ, Sch Med, Dept Cardiol, TR-80810 Istanbul, Turkey
[3] Kadir Has Univ, Sch Med, Dept Heart & Vasc Surg, TR-80810 Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Med Sch, Dept Biostat, Istanbul, Turkey
[5] Florence Nightingale Hosp, Biochem Lab, Istanbul, Turkey
[6] Florence Nightingale Hosp, Dept Diabetol & Metab Disorders, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism, hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes, within the CAD group (n = 80), the +/- genotype was found in 39 individuals (48.8%), whereas 25 (31.3%) carried the +/+ genotype, and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49), the -/- genotype was found in 19 individuals (38.8%), 16 (32.7%) carried the +/- genotype, and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-; this genotype was more frequent in patients than in control subjects. However, the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group, but had associations with lipid levels.
引用
收藏
页码:869 / 874
页数:6
相关论文
共 50 条
  • [1] Study of the participation of Lipoprotein Lipase gene polymorphism in coronary artery disease
    Asal, Ghufran Mohammed Hussein
    Al-Janabi, Lamees M.
    Hussein, Nibras Yahya
    [J]. EURASIAN CHEMICAL COMMUNICATIONS, 2022, 4 (07): : 590 - 597
  • [2] Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia
    Pasalic, D
    Sertic, J
    Kunovic, B
    Milicevic, Z
    Pasic, A
    Zrinski-Topic, R
    Ferencak, G
    Stavljenic-Rukavina, A
    [J]. CROATIAN MEDICAL JOURNAL, 2001, 42 (05) : 517 - 522
  • [3] Lipoprotein lipase gene mutations in coronary artery disease
    Minnich, A
    Baloukas, J
    Roederer, G
    Lussier-Cacan, S
    Davignon, J
    Genest, J
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 (05) : 711 - 716
  • [4] Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease
    Daoud, Mohamed S.
    Ataya, Farid S.
    Fouad, Dalia
    Alhazzani, Amal
    Shehata, Afaf I.
    Al-Jafari, Abdulaziz A.
    [J]. BIOMEDICAL REPORTS, 2013, 1 (04) : 573 - 582
  • [5] Association of lipoprotein lipase gene polymorphisms with coronary artery disease
    Anderson, JL
    King, GJ
    Bair, TL
    Elmer, SP
    Muhlestein, JB
    Habashi, J
    Mixson, L
    Carlquist, JF
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) : 1013 - 1020
  • [6] THE HINDIII POLYMORPHISM OF LIPOPROTEIN LIPASE GENE AND LIPID PROFILE IN CAUCASIAN POPULATION OF WEST SIBERIA
    Shakhtshneider, E.
    Ragino, Y.
    Polonskaya, Y.
    Kashtanova, E.
    Nikitin, Y.
    Malyutina, S.
    Voevoda, M.
    [J]. ATHEROSCLEROSIS, 2014, 235 (02) : E100 - E101
  • [7] Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease
    Ferencak, G
    Pasalic, D
    Grskovic, B
    Cheng, S
    Fijal, B
    Sesto, M
    Skodlar, J
    Rukavina, AS
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 541 - 546
  • [8] Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: Meta-analysis
    Cagatay, Penbe
    Susleyici-Duman, Belgin
    Ciftci, Cavlan
    [J]. DISEASE MARKERS, 2007, 23 (03) : 161 - 166
  • [9] Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans
    Larifla, Laurent
    Armand, Christophe
    Bangou, Jacqueline
    Blanchet-Deverly, Anne
    Numeric, Patrick
    Fonteau, Christiane
    Michel, Carl-Thony
    Ferdinand, Severine
    Bourrhis, Veronique
    Velayoudom-Cephise, Fritz-Line
    [J]. PLOS ONE, 2017, 12 (07):
  • [10] Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease
    Su, ZG
    Zhang, SZ
    Hou, YP
    Zhang, L
    Liao, LC
    Xiao, CY
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 677 - 680